Skip to main content
Fig. 10 | BMC Complementary Medicine and Therapies

Fig. 10

From: Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation

Fig. 10

Effect of PDS on HMrSV5 activity A Different concentrations of PDS (1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal) were used for 24 h; B Treatment with 4 concentrations of PDS for 36 h; C Treatment with 4 concentrations of PDS for 48 h; D Comparison chart at different times; ns: P > 0.05; *: P < 0.05; **: P < 0.01; ***: P < 0.001; ****:P < 0.0001

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us